Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-24-022054

PRESIDENT bought 48,387 shares at $0.65 ($31,452)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ryan Charles S. PRESIDENT 2024-08-20 Purchase +48,387 $0.65 $31,452 122,461 D: show line 1 in the form
Open-market purchases · 48,387 sh · avg $0.65 · $31,452
Loading xslF345X05/form4-08222024_090813.xml…